266 related articles for article (PubMed ID: 26542589)
21. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.
Ismiil ND; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Thomas G; Ackerman I; Covens A; Khalifa MA
Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412
[TBL] [Abstract][Full Text] [Related]
22. Impact of coexistent adenomyosis on outcomes of patients with endometrioid endometrial cancer: a propensity score-matched analysis.
Aydin HA; Toptas T; Bozkurt S; Pestereli E; Simsek T
Tumori; 2018; 104(1):60-65. PubMed ID: 29192745
[TBL] [Abstract][Full Text] [Related]
23. Microvessel density (MVD) as a prognosticator in endometrial carcinoma.
Ozalp S; Yalcin OT; Acikalin M; Tanir HM; Oner U; Akkoyunlu A
Eur J Gynaecol Oncol; 2003; 24(3-4):305-8. PubMed ID: 12807245
[TBL] [Abstract][Full Text] [Related]
24. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of co-existent adenomyosis on outcomes and tumor characteristics of endometrial cancer: A meta-analysis.
An M; Duan H; Zhang Y
J Obstet Gynaecol Res; 2020 Sep; 46(9):1851-1863. PubMed ID: 32686169
[TBL] [Abstract][Full Text] [Related]
26. Endometrioid adenocarcinoma arising in adenomyosis in a patient with pelvic organ prolapse-case report.
Wang J; Wang Q; Wang W; Yang J; Xia J; Wei Y
BMC Womens Health; 2023 Mar; 23(1):150. PubMed ID: 36997927
[TBL] [Abstract][Full Text] [Related]
27. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
28. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA
Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences.
Soslow RA; Bissonnette JP; Wilton A; Ferguson SE; Alektiar KM; Duska LR; Oliva E
Am J Surg Pathol; 2007 Jul; 31(7):979-87. PubMed ID: 17592263
[TBL] [Abstract][Full Text] [Related]
30. Adenomyosis as a Risk Factor for Myometrial or Endometrial Neoplasms-Review.
Szubert M; Kozirog E; Wilczynski J
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206475
[TBL] [Abstract][Full Text] [Related]
31. Adenomyosis As a Confounder to Accurate Endometrial Cancer Staging.
Khalifa MA; Atri M; Klein ME; Ghatak S; Murugan P
Semin Ultrasound CT MR; 2019 Aug; 40(4):358-363. PubMed ID: 31375175
[TBL] [Abstract][Full Text] [Related]
32. Prognosis of women with apparent stage I endometrial cancer who had supracervical hysterectomy.
Matsuo K; Machida H; Takiuchi T; Garcia-Sayre J; Yessaian AA; Roman LD
Gynecol Oncol; 2017 Apr; 145(1):41-49. PubMed ID: 28215841
[TBL] [Abstract][Full Text] [Related]
33. Does the presence of adenomyosis and lymphovascular space invasion affect lymph node status in patients with endometrioid adenocarcinoma of the endometrium?
Musa F; Frey MK; Im HB; Chekmareva M; Ellenson LH; Holcomb K
Am J Obstet Gynecol; 2012 Nov; 207(5):417.e1-6. PubMed ID: 22840974
[TBL] [Abstract][Full Text] [Related]
34. Endometrial cancer arising from adenomyosis: Case report and literature review of MRI findings.
Izumi Y; Yamamoto T; Matsunaga N; Ota T; Owaki Y; Shinohara K; Tsuzuki T; Suzuki K
Radiol Case Rep; 2020 Apr; 15(4):427-430. PubMed ID: 32099587
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of adenomyosis in endometrial cancer patients: a systematic review and meta-analysis.
Raffone A; Seracchioli R; Raimondo D; Maletta M; Travaglino A; Raimondo I; Giaquinto I; Orsini B; Insabato L; Pellicano M; Zullo F
Arch Gynecol Obstet; 2021 Jan; 303(1):47-53. PubMed ID: 33098006
[TBL] [Abstract][Full Text] [Related]
36. Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer.
Tomica D; Ramić S; Danolić D; Šušnjar L; Perić-Balja M; Puljiz M
J Obstet Gynaecol; 2018 Jan; 38(1):96-102. PubMed ID: 28764605
[TBL] [Abstract][Full Text] [Related]
37. The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma.
Vance S; Yechieli R; Cogan C; Hanna R; Munkarah A; Elshaikh MA
Gynecol Oncol; 2012 Jul; 126(1):16-9. PubMed ID: 22507535
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological characteristics and survival outcomes of patients with coexistence of adenomyosis and endometrial carcinoma.
Zhang Z; Yang B; Zhang W; Gao X; Zhao C; Zhang X; Wang L; Zhang Y; Zhang F; Zhang H; Shan B
Int J Clin Exp Pathol; 2018; 11(2):956-962. PubMed ID: 31938189
[TBL] [Abstract][Full Text] [Related]
39. Does the FIGO 2009 endometrial cancer staging system more accurately correlate with clinical outcome in different histologies? Revised staging, endometrial cancer, histology.
Page BR; Pappas L; Cooke EW; Gaffney DK
Int J Gynecol Cancer; 2012 May; 22(4):593-8. PubMed ID: 22343970
[TBL] [Abstract][Full Text] [Related]
40. Endometrial Serous Carcinoma Arising From Adenomyosis: A Clinico-Pathological Insight.
Talwar A; Behera P; Ahuja A; Sarkar B; Phulware RH
J Family Reprod Health; 2021 Jun; 15(2):125-129. PubMed ID: 34721602
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
